- Case report
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Dermatofibrosarcoma presenting as a nodule in the breast of a 75-year-old woman: a case report
© Cottier et al; licensee BioMed Central Ltd. 2011
Received: 9 April 2011
Accepted: 5 October 2011
Published: 5 October 2011
Dermatofibrosarcoma protuberans is a rare neoplasm of soft tissues and its location in the breast is extremely uncommon. Confusion is possible with other primary breast lesions.
A 75-year-old Caucasian woman presented with a mass in her left breast 21 years after being diagnosed with invasive ductal carcinoma of the right breast, treated by a right mastectomy and axillary dissection followed by radiotherapy and breast reconstruction. Mammography revealed a dish-shaped skin nodule formation in the upper outer quadrant of her left breast. Echography confirmed the presence of a lesion measuring 1.4 × 0.8 cm. Based on imaging, the diagnosis was a probable angiosarcoma. Due to the presence of a pacemaker for cardiac arrhythmia and full anticoagulation therapy for a pulmonary embolism, magnetic resonance imaging and a biopsy were not done. We proceeded directly to a quadrantectomy and the final diagnosis revealed a dermatofibrosarcoma protuberans, 1. 8 cm in its greatest microscopic dimension, located 0.1 cm from the upper surgical margin. To ensure the wide resection margins required for this type of neoplasm, a re-excision was performed.
A dermatofibrosarcoma protuberans of the breast is an uncommon discovery. The aim of this case report is to highlight the importance of the surgical procedure in cases of the discovery of dermatofibrosarcoma protuberans. Re-excision may be necessary to ensure adequate resection margins.
Dermatofibrosarcoma protuberans (DFSP) is a rare neoplasm of soft tissues described in 1924 by Darier and Ferrand as "progressive recurrent dermatofibroma" and by Hoffmann in 1925 as 'dermatofibrosarcoma protuberans'. This tumor is a dermal spindle cell tumor of intermediate malignancy characterized by a slow evolution, a significant risk of local recurrence and a low rate of metastasization . DFSP typically presents during early or middle adult life in all parts of the body, although more frequently on the trunk, extremities, and head and neck . Its location in the breast is extremely rare and very few cases have been reported in the literature. Confusion is possible with other primary breast lesions [2, 3].
DFSP represents about 1% of soft tissue sarcomas with an estimated incidence of 0.8 to 5.0 cases per million per year [2, 4]. Forty-seven percent of DFSP cases occur on the trunk . Breast localization of DFSP is rare [3, 5]. In most cases, mammography reveals a dense lesion without fat or calcification. Ultrasound exploration identifies the lesion in the dermis or subcutaneous tissue and the use of Doppler shows hypervascularization of the area . Even in a patient receiving anticoagulation therapy, core biopsy is an option: this biopsy is essential to obtain a diagnosis in order to plan a one-time wide excision. MRI may be helpful to define the depth of infiltration of the tumor .
Pathologic examination reveals monotonous spindle cells arranged in a storiform pattern, extending to the hypodermal fat in a typical honeycomb pattern . The differential diagnosis includes mainly benign fibrous histiocytoma, and also neurofibroma and myxoid liposarcoma . DFSP cells are typically diffusely positive for CD34, which indicates a close link between this neoplasm and normal CD34 positive dermic dendritic cells . Genetic abnormalities associated with DFSP include a supernumerary ring chromosome, corresponding to the low amplification of sequences of chromosomes 17 and 22, and/or the presence of t(17;22), a balanced reciprocal translocation. This translocation fuses the platelet-derived growth factor beta-chain (PDGF-beta) gene to the collagen type 1, alpha 1 gene . The fusion protein, which has a PDFG-beta-type effect, participates in cell proliferation and can be blocked by tyrosine kinase inhibitors.
Safety margins should be of several centimeters of healthy tissue and should have an anatomical border not invaded at depth. The appropriate distance between free surgical margins and the tumor, however, is not established. Some authors recommend Mohs surgery; micrographic surgery using the microscope to trace out the ramifications as describe by Mohs in 1978. This offers a complete evaluation of the peripheral and deep margins using frozen section or accelerated standard histology [8, 9]. Wide first intention local excision may be preferable in the parts of the body where it is easy (like trunk and limb), resulting in an overall shorter procedure . A plastic surgeon should be present if wound closure difficulties are anticipated.
Local recurrence rate varies between 1.6% and 50% depending on the type of surgery used [6, 10, 11]. Mohs surgery results in extremely low local recurrence rates and, accordingly, a cure rate of up to 98.5% . Regional and distant recurrences are infrequent (regional lymph node metastases and distant metastases, principally in the lung), estimated at less than 5% of cases . Complementary radiation therapy or chemotherapy seem not to bring any benefit . However, specific tyrosine kinase inhibitors (for example imatinib, which inhibits the PDGF-beta receptor) appear promising . Long-term follow-up requires strict monitoring every six to twelve months with ultrasound and biopsy in cases of suspected recurrence. The five-year survival rate of patients with DFSP is over 99% [14, 15].
Breast localization of DFSP is extremely uncommon and can mimic a primary breast tumor. As in other locations of DFSP, surgical excision with adequate resection margins is recommended to ensure local control of the disease. A plastic surgeon should be present if difficulty with the wound closure by first intention is to be expected.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Enzinger and Weiss's Soft Tissue Tumors. Edited by: Weiss SC, Goldblum JR. 2008, Mosby; Elsevier; Philadelphia, 371-382. 5Google Scholar
- Lin JY, Sheen-Chen SM, Hsu W, Huang CC, Ko SF, Eng HL: Dermatofibrosarcoma protuberans of the breast. Tumori. 2008, 94 (6): 861-863.PubMedGoogle Scholar
- Liu SZ, Ho TL, Hsu SM, Zhan HL, Chou CP: Imaging of dermatofibrosarcoma protuberans of breast. Breast J. 2010, 16 (5): 541-543. 10.1111/j.1524-4741.2010.00955.x.View ArticlePubMedGoogle Scholar
- Ruiz-Tovar J, Fernandez GM, Reguero Callejas ME, Aguilera VA, Arano BJ, Cabanas NL: Dermatofibrosarcoma protuberans: review of 20-years experience. Clin Transl Oncol. 2006, 8 (8): 606-610. 10.1007/s12094-006-0067-z.View ArticlePubMedGoogle Scholar
- Lee SJ, Mahoney MC, Shaughnessy E: Dermatofibrosarcoma protuberans of the breast: imaging features and review of the literature. AJR Am J Roentgenol. 2009, 193 (1): W64-W69. 10.2214/AJR.08.2141.View ArticlePubMedGoogle Scholar
- Guillou L: Fibroblastic and fibrohistiocytic tumors. Bone and Soft Tissue Pathology, Foundations in Diagnostic Pathology series. Edited by: Folpe AL, Inwards C. 2010, Saunders; Elsevier; Philadelphia, 79-83.Google Scholar
- Lemm D, Mugge LO, Mentzel T, Hoffken K: Current treatment options in dermatofibrosarcoma protuberans. J Cancer Res Clin Oncol. 2009, 135 (5): 653-665. 10.1007/s00432-009-0550-3.View ArticlePubMedGoogle Scholar
- Mohs FE: Chemosurgery for the microscopically controlled excision of cutaneous cancer. Head Neck Surg. 1978, 1 (2): 150-166. 10.1002/hed.2890010209.View ArticlePubMedGoogle Scholar
- Paradisi A, Abeni D, Rusciani A, Cigna E, Wolter M, Scuderi N, Rusciani L, Kaufmann R, Podda M: Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery. Cancer Treat Rev. 2008, 34 (8): 728-736. 10.1016/j.ctrv.2008.06.002.View ArticlePubMedGoogle Scholar
- Gloster HM, Harris KR, Roenigk RK: A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996, 35 (1): 82-87.PubMedGoogle Scholar
- Rutgers EJ, Kroon BB, Albus-Lutter CE, Gortzak E: Dermatofibrosarcoma protuberans: treatment and prognosis. Eur J Surg Oncol. 1992, 18 (3): 241-248.PubMedGoogle Scholar
- Snow SN, Gordon EM, Larson PO, Bagheri MM, Bentz ML, Sable DB: Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature. Cancer. 2004, 101 (1): 28-38. 10.1002/cncr.20316.View ArticlePubMedGoogle Scholar
- Grimer R, Judson I, Peake D, Seddon B: Guidelines for the management of soft tissue sarcomas. Sarcoma. 2010, 2010: 506182-PubMedPubMed CentralGoogle Scholar
- National Comprehensive Cancer Network Dermatofibrosarcoma Protuberans and Merkel Cell Carcinoma: Dermatofibrosarcoma protuberans. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2004, 2 (1): 74-78.Google Scholar
- Dragoumis DM, Katsohi LA, Amplianitis IK, Tsiftsoglou AP: Late local recurrence of dermatofibrosarcoma protuberans in the skin of female breast. World J Surg Oncol. 2010, 8: 48-10.1186/1477-7819-8-48.View ArticlePubMedPubMed CentralGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.